GCM
Gladius Capital Management Portfolio holdings
AUM
$63.8M
1-Year Return
3.49%
This Quarter Return
+2.89%
1 Year Return
+3.49%
3 Year Return
+10.82%
5 Year Return
+16.08%
10 Year Return
+49.7%
AUM
$159M
AUM Growth
-$189M
(-54%)
Cap. Flow
-$205M
Cap. Flow
% of AUM
-129.16%
Top 10 Holdings %
Top 10 Hldgs %
79.43%
Holding
353
New
53
Increased
77
Reduced
94
Closed
116
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$80.3M |
| 2 |
Micron Technology
MU
|
$4.69M |
| 3 |
Exxon Mobil
XOM
|
$3.1M |
| 4 |
Hilton Worldwide
HLT
|
$1.15M |
| 5 |
Booz Allen Hamilton
BAH
|
$1.04M |
Top Sells
| 1 |
Microsoft
MSFT
|
$45M |
| 2 |
Apple
AAPL
|
$28.7M |
| 3 |
NVIDIA
NVDA
|
$26.6M |
| 4 |
Amazon
AMZN
|
$22.8M |
| 5 |
Advanced Micro Devices
AMD
|
$22.2M |
Sector Composition
| 1 | Technology | 10.96% |
| 2 | Industrials | 4.64% |
| 3 | Healthcare | 4.44% |
| 4 | Consumer Discretionary | 3.42% |
| 5 | Energy | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TARO
151
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $36.9K | 0.01% |
882
+76
| +9% | +$3.18K |
|
152
Comp X International
CIX
$290M
| $36.7K | 0.01% |
+1,452
| New | +$36.7K |
|
153
Supernus Pharmaceuticals
SUPN
$2.57B
| $36.6K | 0.01% |
1,265
+310
| +32% | +$8.97K |
|
154
Biogen
BIIB
$20.8B
| $36.5K | 0.01% |
141
+32
| +29% | +$8.28K |
|
155
Wabash National
WNC
$472M
| $36.5K | 0.01% |
+1,424
| New | +$36.5K |
|
156
Phillips 66
PSX
$52.8B
| $36.5K | 0.01% |
+274
| New | +$36.5K |
|
157
Emerald Holding
EEX
$1.03B
| $36.2K | 0.01% |
6,055
-1,222
| -17% | -$7.31K |
|
|
KAMN
158
DELISTED
Kaman Corp
KAMN
| $36K | 0.01% |
+1,502
| New | +$36K |
|
159
StoneX
SNEX
$5.37B
| $36K | 0.01% |
731
-149
| -17% | -$7.33K |
|
160
NETGEAR
NTGR
$804M
| $35.8K | 0.01% |
2,457
-168
| -6% | -$2.45K |
|
161
Perrigo
PRGO
$3.14B
| $35.8K | 0.01% |
1,111
+304
| +38% | +$9.78K |
|
162
Corcept Therapeutics
CORT
$7.26B
| $35.7K | 0.01% |
+1,098
| New | +$35.7K |
|
163
Scansource
SCSC
$981M
| $35.6K | 0.01% |
898
-301
| -25% | -$11.9K |
|
164
ODP
ODP
$658M
| $35.5K | 0.01% |
631
-91
| -13% | -$5.12K |
|
165
Oxford Industries
OXM
$630M
| $35.3K | 0.01% |
353
+21
| +6% | +$2.1K |
|
166
Sylvamo
SLVM
$1.82B
| $35.3K | 0.01% |
718
-12
| -2% | -$589 |
|
167
Park-Ohio Holdings
PKOH
$299M
| $35.2K | 0.01% |
1,306
-552
| -30% | -$14.9K |
|
168
Adtran
ADTN
$780M
| $34.9K | 0.01% |
4,761
+1,081
| +29% | +$7.94K |
|
169
Ethan Allen Interiors
ETD
$767M
| $34.9K | 0.01% |
1,092
-53
| -5% | -$1.69K |
|
170
Marathon Petroleum
MPC
$54.3B
| $34.7K | 0.01% |
234
-26
| -10% | -$3.86K |
|
171
Myers Industries
MYE
$603M
| $34.4K | 0.01% |
1,759
-77
| -4% | -$1.51K |
|
|
ITOS
172
DELISTED
iTeos Therapeutics
ITOS
| $34.3K | 0.01% |
3,131
+1,026
| +49% | +$11.2K |
|
|
LGF.A
173
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $34.2K | 0.01% |
+3,139
| New | +$34.2K |
|
174
iRadimed
IRMD
$914M
| $34K | 0.01% |
717
-92
| -11% | -$4.37K |
|
175
Gilead Sciences
GILD
$143B
| $33.9K | 0.01% |
+418
| New | +$33.9K |
|